Search
BETMIGA 50 MG, Comprimé pelliculé à libération prolongée
Details
| --- | Description |
|---|---|
| Pack | Boite de 30 |
| Strength (Dosage) | 50 MG |
| Laboratory | LAPROPHAN |
| Ingredients | mirabégron |
| Therapeutic class | Spasmolytique urinaire |
| ATC code | G04BD12 |
| PPH | $30.60 |
| PPV | $46.20 |
| Refundable | No |
| Refund base | $0.00 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | Traitement symptomatique de l’impériosité urinaire et de la pollakiurie et/ou de l’incontinence urinaire par impériosité pouvant survenir chez les patients adultes présentant un syndrome d’hyperactivité vésicale (HAV). |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem